THE CONSTRUCT (RESIDUES 117-213) WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG ...THE CONSTRUCT (RESIDUES 117-213) WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. RESIDUE NUMBERING IS BASED ON UNIPROTKB ID P42679.
-
実験情報
-
実験
実験
手法: X線回折 / 使用した結晶の数: 1
-
試料調製
結晶
マシュー密度: 2.08 Å3/Da / 溶媒含有率: 40.85 %
結晶化
温度: 277 K / 手法: 蒸気拡散法, シッティングドロップ法 / pH: 6 詳細: 2.40M (NH4)2SO4, 0.1M MES pH 6.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K
解像度: 1.5→25.593 Å / Num. obs: 14591 / % possible obs: 96.9 % / Observed criterion σ(I): -3 / 冗長度: 5.02 % / Biso Wilson estimate: 23.592 Å2 / Rmerge(I) obs: 0.047 / Net I/σ(I): 16.87
反射 シェル
Diffraction-ID: 1
解像度 (Å)
冗長度 (%)
Rmerge(I) obs
Mean I/σ(I) obs
Num. measured obs
Num. unique obs
% possible all
1.5-1.54
4.76
0.481
3.29
4927
1036
93.6
1.54-1.58
0.346
4.9
5226
1049
97.8
1.58-1.63
0.263
6.1
5003
996
96.8
1.63-1.68
0.212
7.4
4979
1002
96.2
1.68-1.73
0.154
9.3
4963
991
97.3
1.73-1.79
0.106
12.3
4526
923
97.5
1.79-1.86
0.092
14.1
4431
884
98.2
1.86-1.94
0.071
16.9
4239
872
97.4
1.94-2.02
0.057
19.5
4073
823
97.9
2.02-2.12
0.057
22.7
4359
817
98.4
2.12-2.24
0.058
24
4085
757
97.2
2.24-2.37
0.053
25.1
3915
734
98.3
2.37-2.54
0.05
26.3
3563
669
99
2.54-2.74
0.045
27.8
3273
629
99.1
2.74-3
0.045
28.2
3001
593
98.2
3-3.36
0.043
29.9
2753
537
98
3.36-3.87
0.04
30.7
2411
472
98.3
3.87-4.75
0.038
29.2
1785
385
94.4
4.75-6.71
0.041
28.2
1281
290
91.8
6.71-25.593
0.036
25.5
481
132
71.7
-
位相決定
位相決定
手法: 多波長異常分散
-
解析
ソフトウェア
名称
バージョン
分類
NB
MolProbity
3beta29
モデル構築
PDB_EXTRACT
3.1
データ抽出
SHELX
位相決定
SHARP
位相決定
XSCALE
December6, 2010
データスケーリング
BUSTER-TNT
2.10.0
精密化
XDS
データ削減
SHELXD
位相決定
BUSTER
2.10.0
精密化
精密化
構造決定の手法: 多波長異常分散 / 解像度: 1.5→25.593 Å / Cor.coef. Fo:Fc: 0.9632 / Cor.coef. Fo:Fc free: 0.9639 / Occupancy max: 1 / Occupancy min: 0.3 / 交差検証法: THROUGHOUT / σ(F): 0 詳細: 1. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. HOWEVER, THE SE-MET SIDE-CHAIN IS DISORDERED. 2. ATOM RECORD CONTAINS SUM OF TLS AND ...詳細: 1. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. HOWEVER, THE SE-MET SIDE-CHAIN IS DISORDERED. 2. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U FACTORS. 3. SULFATE MODELED IS PRESENT IN CRYSTALLIZATION CONDITIONS. 4. MAD RESTRAINTS (HL COEFFICIENTS) WERE USED DURING REFINEMENT.